CRISPR Therapeutics Management
Management criteria checks 3/4
CRISPR Therapeutics' CEO is Sam Kulkarni, appointed in Dec 2017, has a tenure of 6.42 years. total yearly compensation is $12.32M, comprised of 5.9% salary and 94.1% bonuses, including company stock and options. directly owns 0.48% of the company’s shares, worth R$112.24M. The average tenure of the management team and the board of directors is 5.5 years and 4.9 years respectively.
Key information
Sam Kulkarni
Chief executive officer
US$12.3m
Total compensation
CEO salary percentage | 5.9% |
CEO tenure | 6.4yrs |
CEO ownership | 0.5% |
Management average tenure | 5.5yrs |
Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$12m | US$725k | -US$154m |
Sep 30 2023 | n/a | n/a | -US$354m |
Jun 30 2023 | n/a | n/a | -US$416m |
Mar 31 2023 | n/a | n/a | -US$524m |
Dec 31 2022 | US$21m | US$700k | -US$650m |
Sep 30 2022 | n/a | n/a | -US$681m |
Jun 30 2022 | n/a | n/a | -US$633m |
Mar 31 2022 | n/a | n/a | US$312m |
Dec 31 2021 | US$17m | US$670k | US$378m |
Sep 30 2021 | n/a | n/a | US$412m |
Jun 30 2021 | n/a | n/a | US$447m |
Mar 31 2021 | n/a | n/a | -US$392m |
Dec 31 2020 | US$9m | US$625k | -US$349m |
Sep 30 2020 | n/a | n/a | -US$211m |
Jun 30 2020 | n/a | n/a | US$20m |
Mar 31 2020 | n/a | n/a | US$46m |
Dec 31 2019 | US$16m | US$550k | US$67m |
Sep 30 2019 | n/a | n/a | -US$11m |
Jun 30 2019 | n/a | n/a | -US$200m |
Mar 31 2019 | n/a | n/a | -US$185m |
Dec 31 2018 | US$10m | US$518k | -US$165m |
Sep 30 2018 | n/a | n/a | -US$117m |
Jun 30 2018 | n/a | n/a | -US$91m |
Mar 31 2018 | n/a | n/a | -US$75m |
Dec 31 2017 | US$7m | US$405k | -US$68m |
Compensation vs Market: Sam's total compensation ($USD12.32M) is above average for companies of similar size in the BR market ($USD1.51M).
Compensation vs Earnings: Sam's compensation has been consistent with company performance over the past year.
CEO
Sam Kulkarni (45 yo)
6.4yrs
Tenure
US$12,322,196
Compensation
Dr. Samarth Kulkarni, Ph D., also known as Sam, has been an Independent Director of Repare Therapeutics Inc. since November 2019. Dr. Kulkarni serves as an Independent Non-Executive Director of Centessa Ph...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 6.4yrs | US$12.32m | 0.48% $ 112.2m | |
Chief Financial Officer | 1.2yrs | US$5.91m | 0.012% $ 2.7m | |
General Counsel & Secretary | 7yrs | US$3.51m | 0.072% $ 16.8m | |
Founder | no data | no data | no data | |
Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Head of Technical Operations | 4.6yrs | no data | no data | |
Vice President of Corporate Communications & Investor Relations | no data | no data | no data | |
Head of Human Resources | no data | no data | no data |
5.5yrs
Average Tenure
48yo
Average Age
Experienced Management: C2RS34's management team is seasoned and experienced (5.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 5.9yrs | US$12.32m | 0.48% $ 112.2m | |
Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Lead Independent Director | 3.9yrs | US$552.56k | 0.0024% $ 550.9k | |
Independent Director | 9.1yrs | US$545.06k | 0.00032% $ 74.7k | |
Independent Director | 4.9yrs | US$532.56k | 0% $ 0 | |
Independent Director | 9.1yrs | US$542.56k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 4.9yrs | US$555.06k | 0% $ 0 | |
Independent Director | 2.9yrs | US$536.24k | 0% $ 0 |
4.9yrs
Average Tenure
57yo
Average Age
Experienced Board: C2RS34's board of directors are considered experienced (4.9 years average tenure).